ADVAXIS
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ADVAXIS and buy or sell other stocks, ETFs, and their options commission-free!About ADXS
Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins.
CEOKen Berlin
CEOKen Berlin
Employees15
Employees15
HeadquartersPrinceton, New Jersey
HeadquartersPrinceton, New Jersey
Founded1987
Founded1987
Employees15
Employees15
ADXS Key Statistics
Market cap112.87K
Market cap112.87K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume3.94K
Average volume3.94K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$51.60
52 Week high$51.60
52 Week low$1.02
52 Week low$1.02
Stock Snapshot
As of today, ADVAXIS(ADXS) shares are valued at $0.06. The company's market cap stands at 112.87K.
On 2025-11-25, ADVAXIS(ADXS) stock opened at —, reached a high of —, and a low of —.
ADVAXIS(ADXS) shares are trading with a volume of 0, against a daily average of 3.94K.
In the last year, ADVAXIS(ADXS) shares hit a 52-week high of $51.60 and a 52-week low of $1.02.
In the last year, ADVAXIS(ADXS) shares hit a 52-week high of $51.60 and a 52-week low of $1.02.
People also own
Based on the portfolios of people who own ADXS. This list is generated using Robinhood data, and it’s not a recommendation.